Healthtech Late Stage Investors & VC Firms
847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.
Leeds
New YorkGrowth–Late Stage$40M
Radix Ventures
WarsawSeed–Late Stage$550K – $2.8M
9 people
Korea Investment Partners
SeoulSeed–Late Stage$973K – $50M
17 people
PAI Partners
ParisGrowth–Late Stage$108M – $324M
8 people
Prolog Ventures
ClaytonSeries A–Late Stage$250K – $1M
5 people
Salveo Capital
NorthbrookSeed–Late Stage
8 people
Swordfish Investments
LondonSeed–Late Stage
1 person
VNV Global
StockholmPre-Seed–Late Stage
1 person
Cinven
LondonSeries B–Late Stage
Flow Capital
TorontoGrowth–Late Stage
Prospect Venture Partners
Menlo ParkSeed–Late Stage$3M – $5M
3 people
AIMCo private equity
EdmontonGrowth–Late Stage
14 people
Chrysalis Ventures
LouisvilleSeries A–Late Stage$1M – $10M
5 people
LEAD
OrlandoPre-Seed–Late Stage$100K – $1M
11 people
Lemhi Ventures
JordanSeed–Late Stage$500K – $5M
5 people
RH Managers
JohannesburgSeed–Late Stage
14 people
Sodero
NantesSeed–Late Stage$162K – $5.4M
11 people
ALIVE Israel HealthTech Fund
SavyonSeed–Late Stage
10 people
BackingMinds
StockholmPre-Seed–Late Stage$550K – $3.3M
10 people
TCP Venture Capital
BaltimoreSeed–Late Stage
5 people
QuestMark Partners
Ellicott CityGrowth–Late Stage$5M – $15M
2 people
Evidity Health Capital
New YorkGrowth–Late Stage$5M
5 people
6 Dimensions Capital
Grand CaymanSeed–Late Stage
19 people
BioStar Capital
CharlevoixSeed–Late Stage$250K – $3M
10 people
Related lists
Healthtech Investors & VC Firms (3208)Late Stage Investors & VC Firms (2864)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Late Stage Investors & VC Firms in United States (1101)Late Stage Investors & VC Firms in Global (857)
Data sourced from public filings and firms' own websites — see our methodology.






































